相关实验视频
Updated: May 6, 2026
11:18
Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
8.1K
丹麦急性心力衰竭指南推的治疗方法的利用模式和决定因素
George Frederick Mkoma1,2, Anders Hviid1,3, Björn Pasternak1,4
1Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
European heart journal. Acute cardiovascular care
|November 25, 2025
概括
循环利尿剂通常用于急性心力衰竭 (AHF) 住院治疗. 然而,血管扩张剂,内托普和血管压缩剂的使用较少,这突出了AHF住院患者管理的复杂性.
科学领域:
- 心脏病学 心脏病学
- 临床医学 临床医学
- 药理学 药理学 是一个学科.
背景情况:
- 急性心力衰竭 (AHF) 是住院和患者不良结果的重要原因.
- 目前慢性心力衰竭 (HF) 的管理包括指导方针导向的医学治疗,但急性护理策略有所不同.
- 对于AHF的住院治疗往往需要使用利尿剂,血管扩张剂,内和血管压缩剂.
研究的目的:
- 调查使用模式,剂量策略和指导方针推治疗的影响因素,在住院患者的AHF.
- 分析AHF患者的循环利尿剂,血管扩展剂,内托普剂和血管压缩剂的住院治疗.
- 为了确定与使用这些急性心力衰竭药物相关的患者特征.
主要方法:
- 一项基于登记的全国性队列研究使用了来自丹麦心力衰竭登记册的数据.
- 该研究包括6,009名45岁或以上的患者,他们在2018年至2023年期间住院治疗AHF (左心室喷射率[LVEF] ≤40%).
- 数据与国家医疗保健登记处进行了链接,以确定关键AHF药物的住院使用和剂量.
主要成果:
- 循环利尿剂给了88.7%的患者,富洛塞米德的中位数剂量为50毫克 (亲肠道) 和40毫克 (口服).
- 血管扩张剂在36.1%的病例中使用,内类药物在3.0%,血管压缩剂在8.4%.
- 老年患者 (≥75岁),严重的HF (LVEF<25%),慢性病和经常性住院病例与使用这些疗法的变化有关.
结论:
- 循环利尿剂是住院AHF治疗的主要支柱,其利用率很高.
- 血管扩张剂,异型药物和血管压缩剂的使用率要低得多,这表明当前治疗方案中存在潜在的差距或复杂性.
- 需要进一步的研究来了解AHF治疗中观察到的变异及其对患者结果的影响.
相关概念视频
01:22Heart Failure Drugs: Diuretics
2.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
2.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
1.4K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.4K
01:30Heart Failure V: Medical Management
642
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
642
01:22Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
01:30Heart Failure VII: Nursing Interventions
807
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
807